Avicanna Inc. (OTCMKTS:AVCNF) Short Interest Update

Avicanna Inc. (OTCMKTS:AVCNF) was the target of a large increase in short interest in June. As of June 30th, there was short interest totaling 205,778 shares, an increase of 402.1% from the June 15th total of 40,987 shares. Based on an average trading volume of 158,451 shares, the days-to-cover ratio is presently 1.3 days.

Avicanna Price Performance

Shares of OTCMKTS AVCNF opened at $0.10 on Friday. Avicanna has a fifty-two week low of $0.07 and a fifty-two week high of $0.24. The stock’s 50-day simple moving average is $0.09 and its 200-day simple moving average is $0.12.

About Avicanna

Avicanna Inc, a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets worldwide. It commercializes approximately thirty proprietary evidence-based finished products. The company provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific pharmaceutical products to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, such as Trunerox, an adjuvant treatment for seizures associated with Lennox-Gastaut Syndrome and Dravet Syndrome.